1-11 of 11
Larry R. Kaiser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers

Africa Wallace, Veena Kapoor, Jing Sun, Paul Mrass, Wolfgang Weninger, Daniel F. Heitjan, Carl June, Larry R. Kaiser, Leona E. Ling, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (12): 3966–3974.
https://doi.org/10.1158/1078-0432.CCR-08-0356
Published: 16 June 2008
View article titled, Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers
Open the PDF for Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers in another window
Journal Articles

A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses

Daniel H. Sterman, Adri Recio, Richard G. Carroll, Colin T. Gillespie, Andrew Haas, Anil Vachani, Veena Kapoor, Jing Sun, Richard Hodinka, Jennifer L. Brown, Michael J. Corbley, Michael Parr, Mitchell Ho, Ira Pastan, Michael Machuzak, William Benedict, Xin-qiao Zhang, Elaina M. Lord, Leslie A. Litzky, Daniel F. Heitjan, Carl H. June, Larry R. Kaiser, Robert H. Vonderheide, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4456–4466.
https://doi.org/10.1158/1078-0432.CCR-07-0403
Published: 01 August 2007
View article titled, A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses
Open the PDF for A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses in another window
Journal Articles

A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell Carcinoma

Anil Vachani, Michael Nebozhyn, Sunil Singhal, Linda Alila, Elliot Wakeam, Ruth Muschel, Charles A. Powell, Patrick Gaffney, Bhuvanesh Singh, Marcia S. Brose, Leslie A. Litzky, John Kucharczuk, Larry R. Kaiser, J. Stephen Marron, Michael K. Showe, Steven M. Albelda, Louise C. Showe
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 2905–2915.
https://doi.org/10.1158/1078-0432.CCR-06-1670
Published: 15 May 2007
View article titled, A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell Carcinoma
Open the PDF for A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Long-term Follow-up of Patients with Malignant Pleural Mesothelioma Receiving High-Dose Adenovirus Herpes Simplex Thymidine Kinase/Ganciclovir Suicide Gene Therapy

Daniel H. Sterman, Adriana Recio, Anil Vachani, Jing Sun, Lumei Cheung, Peter DeLong, Kunjlata M. Amin, Leslie A. Litzky, James M. Wilson, Larry R. Kaiser, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (20): 7444–7453.
https://doi.org/10.1158/1078-0432.CCR-05-0405
Published: 20 October 2005
View article titled, Long-term Follow-up of Patients with Malignant Pleural Mesothelioma Receiving High-Dose Adenovirus Herpes Simplex Thymidine Kinase/Ganciclovir Suicide Gene Therapy
Open the PDF for Long-term Follow-up of Patients with Malignant Pleural Mesothelioma Receiving High-Dose Adenovirus Herpes Simplex Thymidine Kinase/Ganciclovir Suicide Gene Therapy in another window
Journal Articles

Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity

Eiji Suzuki, Veena Kapoor, Arminder Singh Jassar, Larry R. Kaiser, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6713–6721.
https://doi.org/10.1158/1078-0432.CCR-05-0883
Published: 15 September 2005
View article titled, Gemcitabine Selectively Eliminates Splenic Gr-1<sup>+</sup>/CD11b<sup>+</sup> Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
Open the PDF for Gemcitabine Selectively Eliminates Splenic Gr-1<sup>+</sup>/CD11b<sup>+</sup> Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity in another window
Journal Articles

Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A Review

Sunil Singhal, Anil Vachani, Danielle Antin-Ozerkis, Larry R. Kaiser, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (11): 3974–3986.
https://doi.org/10.1158/1078-0432.CCR-04-2661
Published: 01 June 2005
View article titled, Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A Review
Open the PDF for Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A Review in another window
Journal Articles

Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity

Eiji Suzuki, Veena Kapoor, H.-Kam Cheung, Leona E. Ling, Peter A. DeLong, Larry R. Kaiser, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (17): 5907–5918.
https://doi.org/10.1158/1078-0432.CCR-03-0611
Published: 08 September 2004
View article titled, Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity
Open the PDF for Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity in another window
Journal Articles

Alterations of the Tumor Suppressor Gene Parkin in Non-Small Cell Lung Cancer

Maria Cristina Picchio, Eric Santos Martin, Rossano Cesari, George Adrian Calin, Sai Yendamuri, Tamotsu Kuroki, Francesca Pentimalli, Manuela Sarti, Kristine Yoder, Larry R. Kaiser, Richard Fishel, Carlo Maria Croce
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (8): 2720–2724.
https://doi.org/10.1158/1078-0432.CCR-03-0086
Published: 20 April 2004
View article titled, Alterations of the Tumor Suppressor Gene <em>Parkin</em> in Non-Small Cell Lung Cancer
Open the PDF for Alterations of the Tumor Suppressor Gene <em>Parkin</em> in Non-Small Cell Lung Cancer in another window
Journal Articles

Gene Expression Profiling of Malignant Mesothelioma

Sunil Singhal, Rainer Wiewrodt, Liliana D. Malden, Kunjlata M. Amin, Kimberly Matzie, Joseph Friedberg, John C. Kucharczuk, Leslie A. Litzky, Steven W. Johnson, Larry R. Kaiser, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (8): 3080–3097.
Published: 11 August 2003
View article titled, Gene Expression Profiling of Malignant Mesothelioma
Open the PDF for Gene Expression Profiling of Malignant Mesothelioma in another window
Journal Articles

TRANCE- and CD40 Ligand-matured Dendritic Cells Reveal MHC Class I-restricted T Cells Specific for Autologous Tumor in Late-Stage Ovarian Cancer Patients

Katia Schlienger, Christina S. Chu, Edward Y. Woo, Patricia M. Rivers, Alanna J. Toll, Brian Hudson, Marcela V. Maus, James L. Riley, Yongwon Choi, George Coukos, Larry R. Kaiser, Stephen C. Rubin, Bruce L. Levine, Richard G. Carroll, Carl H. June
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1517–1527.
Published: 01 April 2003
View article titled, TRANCE- and CD40 Ligand-matured Dendritic Cells Reveal MHC Class I-restricted T Cells Specific for Autologous Tumor in Late-Stage Ovarian Cancer Patients
Open the PDF for TRANCE- and CD40 Ligand-matured Dendritic Cells Reveal MHC Class I-restricted T Cells Specific for Autologous Tumor in Late-Stage Ovarian Cancer Patients in another window
Journal Articles

Use of Carrier Cells to Deliver a Replication-selective Herpes Simplex Virus-1 Mutant for the Intraperitoneal Therapy of Epithelial Ovarian Cancer

George Coukos, Antonis Makrigiannakis, Eugene H. Kang, David Caparelli, Ivor Benjamin, Larry R. Kaiser, Stephen C. Rubin, Steven M. Albelda, Katherine L. Molnar-Kimber
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (6): 1523–1537.
Published: 01 June 1999
View article titled, Use of Carrier Cells to Deliver a Replication-selective Herpes Simplex Virus-1 Mutant for the Intraperitoneal Therapy of Epithelial Ovarian Cancer
Open the PDF for Use of Carrier Cells to Deliver a Replication-selective Herpes Simplex Virus-1 Mutant for the Intraperitoneal Therapy of Epithelial Ovarian Cancer in another window